Skip to main navigation
Close
Main navigation
Advocacy
Issue Overview
#Rx4StateSavings
#4GRxANTED
#MarkupMadness
State Advocacy
GDUFA/BsUFA User Fees
Biosimilars Council
Action Center
Our Impact
Join
About Us
Generic Quality
About AAM
Our Team
Our Members
Generic Medicines
Biosimilars Council
Meet Our Board
Social Commitment
Careers
Contact Us
Stories
Events
Resources
All Resources
Drug Shortages White Paper
2023 Savings Report
Supply Chain Blueprint
Biosimilars Patient Resource Center
Biosimilar Research & Studies
Press Releases
Blog
Founders Blogs
Amicus Briefs
Take Action
Menu
New White Paper
- Read AAM Report on Drug Shortages
Learn More
Close
Breadcrumb
Association for Accessible Medicines
Resources
Blog
Blog
Share
Blog
Oct 14, 2022
| Jewel Smith
Member Spotlight: Meitheal Pharmaceuticals
Blog
Oct 3, 2022
| Monét Stanford
Generics & Biosimilars Continue to Reward Patients, Employers and Taxpayers
Blog
Sep 29, 2022
| Erica Klinger
October Can Now Afford to do More to Support Her Mental Health
Blog
Sep 15, 2022
| Model B
2022 Report
Blog
Sep 6, 2022
| Craig Burton
Explosive Growth in Drug Discount Cards is a Symptom of a Broken System
Blog
Jul 28, 2022
| Dan Leonard
AAM All Access Podcast: Medicare Drug Price Negotiation is Bad for Patients
Blog
Jul 25, 2022
| Craig Burton
Drug Price Negotiation Proposals Undermine Current Bipartisan Approaches to Lower Drug Spending
Blog
Jul 21, 2022
| Dan Leonard
AAM All Access Podcast: CMMB’s Urgent Mission
Blog
Jul 20, 2022
| Craig Burton
The Evidence Is Clear: Biosimilar Competition Will Achieve More Savings for Patients Than Build Back Better’s Negotiations
Blog
Jul 20, 2022
| Craig Burton
Medicare Negotiations Serve as a Catalyst to a Perpetual Monopoly
Blog
Jul 20, 2022
| Craig Burton
Proposed BBB Negotiation Framework Discourages Biosimilar Competition, Imposes Higher Costs on Commercially Insured Patients and Their Employers
Blog
Jul 12, 2022
| Monét Stanford
Despite Enrollment In Medicare Prescription Drug Coverage, Over Half of All Seniors Pay Full Cost for Many Generic Drugs
Load More
Advocacy
Issue Overview
#Rx4StateSavings
#4GRxANTED
#MarkupMadness
State Advocacy
GDUFA/BsUFA User Fees
Biosimilars Council
Action Center
Our Impact
Join
About Us
Generic Quality
About AAM
Our Team
Our Members
Generic Medicines
Biosimilars Council
Meet Our Board
Social Commitment
Careers
Contact Us
Stories
Events
GRx+Biosims 2022
Access! 2022
Resources
All Resources
Drug Shortages White Paper
2023 Savings Report
Supply Chain Blueprint
Biosimilars Patient Resource Center
Biosimilar Research & Studies
Press Releases
Blog
Founders Blogs
Amicus Briefs
Take Action